Clinical Trial Update: Multi-center MRD Registry for Inflammatory Breast Cancer

View source ↗

Summary

A multi-center registry study evaluating minimal residual disease in inflammatory breast cancer, currently recruiting at MD Anderson Cancer Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Inflammatory Breast Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Status: RECRUITING